← Leaderboards
Lindsay Jane Collin
Utah State Higher Education System--University Of Utah
$580,999
Attributed
$580,999
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $248.9K · FY2019–25$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$580,999 · 3
By mechanism
K99$279,172 · 1
R00$248,858 · 1
F31$52,969 · 1
Top collaborators
No co-investigators on record.
Most similar at Utah State Higher Education System--University Of Utah
Same institution · by research overlap
- David W Wetter$26,188,223
- Cho Yan Lam$6,979,775
- Polina Kukhareva$161,664
Others in their field
Other Emerging Leaders on “Recurrence”
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Kevin Navin Sheth · Brigham And Women'S Hospital$10,362,027
- Dale Sandler · Social And Scientific Systems, Inc.$9,632,923
- Zhiyong Yang · Fzata, Inc.$7,816,062
- Kathleen Nicol · Research Inst Nationwide Children'S Hosp$7,152,405
- Phillip W Graham · Research Triangle Institute$7,075,871
Research focus
RecurrenceHigh RiskGuidelinesPrognostic MarkerTumorMolecularClinical TrialsFollow-UpMalignant NeoplasmsPopulation BasedResearch Project GrantsResourcesAffectMortalityCharacteristicsBiologicalCohortDiagnosisCancer RecurrenceCarcinomaAlgorithmsCareer DevelopmentAwardBrca Gene
Grant awards (5)
Identifying factors associated with ovarian cancer recurrence using a population-based approach$248,858
R00 · FY2025 · CA · contact PI
Identifying factors associated with ovarian cancer recurrence using a population-based approach$139,586
K99 · FY2024 · CA · contact PI
Identifying factors associated with ovarian cancer recurrence using a population-based approach$139,586
K99 · FY2023 · CA · contact PI
Biologic and Patient Variation Affecting Breast Cancer Treatment Efficacy$7,953
F31 · FY2020 · CA · contact PI
Biologic and Patient Variation Affecting Breast Cancer Treatment Efficacy$45,016
F31 · FY2019 · CA · contact PI